VisionPoint Advisory Group’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,996
Closed -$236K 525
2026
Q1
$236K Buy
1,996
+125
+7% +$15.5K 0.04% 392
2025
Q4
$235K Sell
1,871
-592
-24% -$77.2K 0.05% 352
2025
Q3
$360K Buy
2,463
+84
+4% +$12.7K 0.07% 261
2025
Q2
$371K Buy
+2,379
New +$377K 0.08% 234
2025
Q1
Sell
-585
Closed -$95.1K 322
2024
Q4
$95.1K Sell
585
-49
-8% -$8.76K 0.03% 237
2024
Q3
$124K Buy
634
+45
+8% +$8.29K 0.04% 210
2024
Q2
$102K Buy
589
+2
+0.3% +$333 0.04% 214
2024
Q1
$99.3K Buy
587
+161
+38% +$30.2K 0.04% 206
2023
Q4
$84.1K Sell
426
-141
-25% -$25K 0.03% 201
2023
Q3
$98.7K Buy
567
+396
+232% +$71.9K 0.04% 193
2023
Q2
$29.4K Buy
+171
New +$29.6K 0.01% 253
2020
Q1
Sell
-2,367
Closed -$313K 158
2019
Q4
$313K Hold
2,367
0.13% 84
2019
Q3
$301K Buy
2,367
+209
+10% +$25.2K 0.08% 101
2019
Q2
$245K Buy
+2,158
New +$226K 0.07% 113

Other funds holding ZTS

VisionPoint Advisory Group's ZTS Position: Q2 2026 in Review

VisionPoint Advisory Group sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 1,996 shares — an estimated $236K sold.

VisionPoint Advisory Group first reported a position in ZTS in Q2 2019 and held it in 14 quarters. The position peaked at $371K in Q2 2025. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • VisionPoint Advisory Group reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • VisionPoint Advisory Group sold 1,996 Zoetis shares in Q2 2026, an estimated $236K.
  • VisionPoint Advisory Group first reported a position in Zoetis in Q2 2019 and held it in 14 quarters.
  • VisionPoint Advisory Group's Zoetis position peaked at $371K in Q2 2025.
  • 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.